Website
N/ATelephone
61.2.9467.0400
Address
Crows Nest Level 3 20 Clarke Street Sydney, New South Wales (NSW) 2065
Description
SomnoMed Ltd. engages in the production and sale of devices for the oral treatment of sleep related disorders. Its products include SomnoDent, SomMorning Repositioner, SomnoBrux, SomTabs, and Sunrise Sleep Test. It operates through the following geographical segments: North America, Europe, and Asia Pacific. The company was founded in 2004 and is headquartered in Sydney, Australia.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.19 - 0.5
Trade Value (12mth)
AU$9,363.00
1 week
11.11%
1 month
75.44%
YTD
33.22%
1 year
43.58%
All time high
4.34
EPS 3 yr Growth
797.30%
EBITDA Margin
-2.80%
Operating Cashflow
-$6m
Free Cash Flow Return
-13.70%
ROIC
-26.50%
Interest Coverage
-0.80
Quick Ratio
1.40
Shares on Issue (Fully Dilluted)
176m
HALO Sector
Healthcare
Next Company Report Date
27-Aug-25
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
AUD
Short Sell (% of issue)
0.00
Date | Announcements |
---|---|
05 December 24 |
Notification regarding unquoted securities - SOM
×
Notification regarding unquoted securities - SOM |
05 December 24 |
Change of Director's Interest Notice
×
Change of Director's Interest Notice |
05 December 24 |
Change of Director's Interest Notice
×
Change of Director's Interest Notice |
05 December 24 |
Change of Director's Interest Notice
×
Change of Director's Interest Notice |
27 November 24 |
FY25 Guidance Upgrade and Appointment of CFO
×
FY25 Guidance Upgrade and Appointment of CFO |
27 November 24 |
Investor Presentation AGM
×
Investor Presentation AGM |
27 November 24 |
AGM Chairman & co-CEO addresses
×
AGM Chairman & co-CEO addresses |
27 November 24 |
AGM results
×
AGM results |
23 October 24 |
Quarterly Activities Report
×
Quarterly Activities Report |
23 October 24 |
Quarterly Appendix 4C Cash Flow Report
×
Quarterly Appendix 4C Cash Flow Report |
17 October 24 |
Notice of Annual General Meeting
×
Notice of Annual General Meeting |
17 October 24 |
Annual General Meeting Proxy Form
×
Annual General Meeting Proxy Form |
08 October 24 |
Final Director's Interest Notice
×
Final Director's Interest Notice |
08 October 24 |
Initial Director's Interest Notice
×
Initial Director's Interest Notice |
07 October 24 |
Rest Assure - US Food and Drug Authority (FDA) Update
×
Rest Assure - US Food and Drug Authority (FDA) Update |
03 October 24 |
Director Appointment/Resignation
×
Director Appointment/Resignation |
30 September 24 |
Annual Report to shareholders
×
Annual Report to shareholders |
30 September 24 |
Appendix 4G
×
Appendix 4G |
30 September 24 |
Corporate Governance Statement
×
Corporate Governance Statement |
23 September 24 |
Change of Director's Interest Notice
×
Change of Director's Interest Notice |
09 September 24 |
Change of Director's Interest Notice
×
Change of Director's Interest Notice |
28 August 24 |
Preliminary Final Report
×
Preliminary Final Report |
28 August 24 |
FY24 Preliminary Report and FY25 Guidance
×
FY24 Preliminary Report and FY25 Guidance |
28 August 24 |
Investor Presentation
×
Investor Presentation |
21 August 24 |
FY24 full year results investor conference call details
×
FY24 full year results investor conference call details |
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.